共 77 条
[1]
Everhart JE(2009)Burden of digestive diseases in the United States part II: lower gastrointestinal diseases Gastroenterology 136 741-754
[2]
Ruhl CE(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2893-2917
[3]
Ferlay J(2007)Strategies for the management of hepatocellular carcinoma Nat Clin Pract Oncol 4 424-432
[4]
Shin HR(2010)Hepatocellular carcinoma: a global view Nat Rev Gastroenterol Hepatol 7 448-458
[5]
Bray F(2001)Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421-430
[6]
Forman D(2004)Yttrium-90 microspheres for the treatment of hepatocellular carcinoma Gastroenterology 127 S194-S205
[7]
Mathers C(2005)Management of hepatocellular carcinoma Hepatology 42 1208-1236
[8]
Parkin DM(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739
[9]
Schwartz M(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171
[10]
Roayaie S(2003)Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429-442